FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1944363718> ?p ?o ?g. }

• W1944363718 endingPage "2320" @default.
• W1944363718 startingPage "2313" @default.
• W1944363718 abstract "PURPOSE To quantify the incidence and severity of tumor lysis syndrome (TLS) as a consequence of fludarabine therapy in patients with advanced chronic lymphocytic leukemia (CLL). PATIENTS AND METHODS A retrospective review and questionnaire follow-up of clinical and laboratory data were performed on patients with intermediate or high-risk CLL on the National Cancer Institute Group C protocol or special exception mechanisms, or phase II trials of fludarabine, for whom adverse drug reports of TLS were available. Fludarabine was administered at a dose of 20 to 40 mg/m2 per day for 5 days at monthly intervals. RESULTS Among the 6,137 patients, TLS was suspected in 26 (0.42%), with clinical and laboratory features consistent with TLS present in 20 (0.33%). Prophylaxis against TLS had been administered to 60% of these patients. Clinical or laboratory features were similar to patients who did not develop TLS. Of the patients with TLS, 90% had high-risk CLL, 60 months of prior disease duration, with a median pretreatment WBC of 109 x 10(9)/L, two prior regimens, lymphadenopathy in 89%, splenomegaly and/or hepatomegaly in 90%. TLS developed on approximately day 7 and lasted a median of 9.5 days. Dialysis was required in 30% during the TLS episode; 20% of patients died during cycle one of fludarabine therapy with renal failure, and another 20% died of infection or congestive heart failure. Six patients were retreated with fludarabine without recurrent TLS. CONCLUSION TLS after fludarabine therapy is extremely uncommon, but may be associated with significant morbidity and mortality." @default.
• W1944363718 created "2016-06-24" @default.
• W1944363718 creator A5009044758 @default.
• W1944363718 creator A5028595129 @default.
• W1944363718 creator A5043149892 @default.
• W1944363718 creator A5065293841 @default.
• W1944363718 creator A5074372066 @default.
• W1944363718 date "1998-07-01" @default.
• W1944363718 modified "2023-09-25" @default.
• W1944363718 title "Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia." @default.
• W1944363718 cites W103174640 @default.
• W1944363718 cites W1484886449 @default.
• W1944363718 cites W1494274243 @default.
• W1944363718 cites W1756818535 @default.
• W1944363718 cites W1839937968 @default.
• W1944363718 cites W1862276309 @default.
• W1944363718 cites W1935154669 @default.
• W1944363718 cites W1966551456 @default.
• W1944363718 cites W1979986112 @default.
• W1944363718 cites W1987570956 @default.
• W1944363718 cites W1988508777 @default.
• W1944363718 cites W2009413625 @default.
• W1944363718 cites W2023021501 @default.
• W1944363718 cites W2023435229 @default.
• W1944363718 cites W2028806024 @default.
• W1944363718 cites W2070193300 @default.
• W1944363718 cites W2085757139 @default.
• W1944363718 cites W2087433521 @default.
• W1944363718 cites W2094679036 @default.
• W1944363718 cites W2146410476 @default.
• W1944363718 cites W2166014786 @default.
• W1944363718 cites W2325388010 @default.
• W1944363718 cites W2332209737 @default.
• W1944363718 cites W2412507018 @default.
• W1944363718 cites W2420952133 @default.
• W1944363718 cites W2426644328 @default.
• W1944363718 cites W2797177778 @default.
• W1944363718 cites W65919465 @default.
• W1944363718 cites W2417269964 @default.
• W1944363718 doi "https://doi.org/10.1200/jco.1998.16.7.2313" @default.
• W1944363718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9667245" @default.
• W1944363718 hasPublicationYear "1998" @default.
• W1944363718 type Work @default.
• W1944363718 sameAs 1944363718 @default.
• W1944363718 citedByCount "78" @default.
• W1944363718 countsByYear W19443637182012 @default.
• W1944363718 countsByYear W19443637182013 @default.
• W1944363718 countsByYear W19443637182014 @default.
• W1944363718 countsByYear W19443637182015 @default.
• W1944363718 countsByYear W19443637182016 @default.
• W1944363718 countsByYear W19443637182017 @default.
• W1944363718 countsByYear W19443637182018 @default.
• W1944363718 countsByYear W19443637182019 @default.
• W1944363718 countsByYear W19443637182020 @default.
• W1944363718 crossrefType "journal-article" @default.
• W1944363718 hasAuthorship W1944363718A5009044758 @default.
• W1944363718 hasAuthorship W1944363718A5028595129 @default.
• W1944363718 hasAuthorship W1944363718A5043149892 @default.
• W1944363718 hasAuthorship W1944363718A5065293841 @default.
• W1944363718 hasAuthorship W1944363718A5074372066 @default.
• W1944363718 hasConcept C120665830 @default.
• W1944363718 hasConcept C121332964 @default.
• W1944363718 hasConcept C126322002 @default.
• W1944363718 hasConcept C141071460 @default.
• W1944363718 hasConcept C2776694085 @default.
• W1944363718 hasConcept C2776755627 @default.
• W1944363718 hasConcept C2777938653 @default.
• W1944363718 hasConcept C2778461978 @default.
• W1944363718 hasConcept C2779263901 @default.
• W1944363718 hasConcept C2779788671 @default.
• W1944363718 hasConcept C61511704 @default.
• W1944363718 hasConcept C71924100 @default.
• W1944363718 hasConceptScore W1944363718C120665830 @default.
• W1944363718 hasConceptScore W1944363718C121332964 @default.
• W1944363718 hasConceptScore W1944363718C126322002 @default.
• W1944363718 hasConceptScore W1944363718C141071460 @default.
• W1944363718 hasConceptScore W1944363718C2776694085 @default.
• W1944363718 hasConceptScore W1944363718C2776755627 @default.
• W1944363718 hasConceptScore W1944363718C2777938653 @default.
• W1944363718 hasConceptScore W1944363718C2778461978 @default.
• W1944363718 hasConceptScore W1944363718C2779263901 @default.
• W1944363718 hasConceptScore W1944363718C2779788671 @default.
• W1944363718 hasConceptScore W1944363718C61511704 @default.
• W1944363718 hasConceptScore W1944363718C71924100 @default.
• W1944363718 hasIssue "7" @default.
• W1944363718 hasLocation W19443637181 @default.
• W1944363718 hasLocation W19443637182 @default.
• W1944363718 hasOpenAccess W1944363718 @default.
• W1944363718 hasPrimaryLocation W19443637181 @default.
• W1944363718 hasRelatedWork W1944363718 @default.
• W1944363718 hasRelatedWork W1951162530 @default.
• W1944363718 hasRelatedWork W1983849106 @default.
• W1944363718 hasRelatedWork W2016875693 @default.
• W1944363718 hasRelatedWork W2023435229 @default.
• W1944363718 hasRelatedWork W2034569503 @default.
• W1944363718 hasRelatedWork W2089145602 @default.
• W1944363718 hasRelatedWork W2413633027 @default.
• W1944363718 hasRelatedWork W2995145164 @default.

• next